Cargando…
Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules
BACKGROUND: Stereotactic body radiotherapy (SBRT) is evolving into a standard of care for unresectable lung nodules. Local control has been shown to be in excess of 90% at 3 years. However, some patients present with synchronous lung nodules in the ipsilateral or contralateral lobe or metasynchronou...
Autores principales: | Owen, Dawn, Olivier, Kenneth R, Mayo, Charles S, Miller, Robert C, Nelson, Kathryn, Bauer, Heather, Brown, Paul D, Park, Sean S, Ma, Daniel J, Garces, Yolanda I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341868/ https://www.ncbi.nlm.nih.gov/pubmed/25889747 http://dx.doi.org/10.1186/s13014-015-0340-9 |
Ejemplares similares
-
Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung
por: Owen, Dawn, et al.
Publicado: (2015) -
Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020) -
Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
por: Dagoglu, Nergiz, et al.
Publicado: (2016) -
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
por: Barney, Brandon M, et al.
Publicado: (2012) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
por: Wegner, Rodney E., et al.
Publicado: (2019)